NeuBase Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • NeuBase Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$88.4K, a 226% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$257K, a 101% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $42.3M, a 27.9% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $33.1M, a 144% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$257K -$42.6M -101% Oct 1, 2021 Sep 30, 2022 10-K 2022-12-21
2021 $42.3M +$9.23M +27.9% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-21
2020 $33.1M +$19.5M +144% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 $13.6M +$13.7M Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2018 -$86.3K -$19.5M -100% Oct 1, 2017 Sep 30, 2018 10-K 2019-01-03
2017 $19.5M +$19.6M Oct 1, 2016 Sep 30, 2017 10-K 2019-01-03
2016 -$150K Oct 1, 2015 Sep 30, 2016 10-K 2017-12-15
2014 $17M +$11.8M +228% Oct 1, 2013 Sep 30, 2014 10-K 2014-12-22
2013 $5.18M +$1.23M +31.1% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-22
2012 $3.95M +$2.97M +302% Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
2011 $981K +$358K +57.4% Oct 1, 2010 Sep 30, 2011 10-K 2013-01-09
2010 $624K Oct 1, 2009 Sep 30, 2010 10-K/A 2012-01-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.